These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 23788085

  • 21. Should patients in cardiogenic shock undergo rescue angioplasty after failed fibrinolysis: comparison of primary versus rescue angioplasty in cardiogenic shock patients.
    Kunadian B, Vijayalakshmi K, Dunning J, Thornley AR, Sutton AG, Muir DF, Wright RA, Hall JA, de Belder MA.
    J Invasive Cardiol; 2007 May; 19(5):217-23. PubMed ID: 17476036
    [Abstract] [Full Text] [Related]

  • 22. Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.
    Rysz J, Banach M, Stolarek RA, Pasnik J, Cialkowska-Rysz A, Koktysz R, Piechota M, Baj Z.
    J Nephrol; 2007 May; 20(4):444-52. PubMed ID: 17879211
    [Abstract] [Full Text] [Related]

  • 23. Plasma MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation. The effect of aprotinin and the relation to ischemia/reperfusion injury.
    Kuyvenhoven JP, Molenaar IQ, Verspaget HW, Veldman MG, Palareti G, Legnani C, Moolenburgh SE, Terpstra OT, Lamers CB, van Hoek B, Porte RJ.
    Thromb Haemost; 2004 Mar; 91(3):506-13. PubMed ID: 14983226
    [Abstract] [Full Text] [Related]

  • 24. Impact of multivessel coronary artery disease on early ischemic injury, late clinical outcome, and remodeling in patients with acute myocardial infarction treated by primary coronary angioplasty.
    Tarantini G, Napodano M, Gasparetto N, Favaretto E, Marra MP, Cacciavillani L, Bilato C, Osto E, Cademartiri F, Musumeci G, Corbetti F, Razzolini R, Iliceto S.
    Coron Artery Dis; 2010 Mar; 21(2):78-86. PubMed ID: 20071979
    [Abstract] [Full Text] [Related]

  • 25. [Rapid resolution of ST segment elevation predicts recovery of left myocardial contraction in patients with acute myocardial infarction treated with percutaneous coronary angioplasty].
    Tomaszuk-Kazberuk A, Korecki J, Kochman W, Dobrzycki S, Musiał WJ.
    Przegl Lek; 2002 Mar; 59(8):638-41. PubMed ID: 12638338
    [Abstract] [Full Text] [Related]

  • 26. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
    Dobrzycki S, Mezyński G, Kralisz P, Prokopczuk P, Nowak K, Kochman W, Zuk J, Bachórzewska-Gajewska H, Sawicki Z, Poniatowski B, Korecki J, Musiał WJ.
    Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
    [Abstract] [Full Text] [Related]

  • 27. Evolution of myocardial perfusion during primary angioplasty in spontaneously reperfused infarct-related artery: impact on long-term clinical outcomes and left ventricular function recovery.
    Zalewski J, Nycz K, Przewlocki T, Durak M, Cul M, Zajdel W, Zmudka K.
    Int J Cardiol; 2011 Feb 17; 147(1):25-31. PubMed ID: 19709768
    [Abstract] [Full Text] [Related]

  • 28. Prognostic value of different serum biomarkers for left ventricular remodelling after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Urbano-Moral JA, Lopez-Haldon JE, Fernandez M, Mancha F, Sanchez A, Rodriguez-Puras MJ, Villa M, Lopez-Pardo F, Diaz de la Llera L, Valle JI, Martinez A.
    Heart; 2012 Aug 17; 98(15):1153-9. PubMed ID: 22572051
    [Abstract] [Full Text] [Related]

  • 29. Primary coronary intervention in diabetic octogenarians with acute ST elevation myocardial infarction.
    Sosnowski C, Janeczko-Sosnowska E, Woźniak J, Jasiński B, Dabrowski R, Sumiński A, Wiernikowski A, Ostrzycki A, Szwed H, Ruzyłło W.
    Kardiol Pol; 2007 Oct 17; 65(10):1181-6; discussion 1187-9. PubMed ID: 17979046
    [Abstract] [Full Text] [Related]

  • 30. [Plasma matrix metalloproteinases MMP-2 and MMP-9 and tissue inhibitors TIMP-1 and TIMP-2 in children treated for acute lymphoblastic leukemia].
    Krawczuk-Rybak M, Kuźmicz M, Mroczko B, Szmitkowski M.
    Pol Merkur Lekarski; 2010 Jul 17; 29(169):14-8. PubMed ID: 20712241
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. One-year clinical outcome of interventionalist- versus patient-transfer strategies for primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: results from the REVERSE-STEMI study.
    Zhang Q, Zhang RY, Qiu JP, Zhang JF, Wang XL, Jiang L, Liao ML, Zhang JS, Hu J, Yang ZK, Shen WF.
    Circ Cardiovasc Qual Outcomes; 2011 May 17; 4(3):355-62. PubMed ID: 21521833
    [Abstract] [Full Text] [Related]

  • 35. Dynamic changes of matrix metalloproteinases and their tissue inhibitors in severe sepsis.
    Mühl D, Nagy B, Woth G, Falusi B, Bogár L, Weber G, Lantos J.
    J Crit Care; 2011 Dec 17; 26(6):550-5. PubMed ID: 21530151
    [Abstract] [Full Text] [Related]

  • 36. Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients.
    Lanchou J, Corbel M, Tanguy M, Germain N, Boichot E, Theret N, Clement B, Lagente V, Malledant Y.
    Crit Care Med; 2003 Feb 17; 31(2):536-42. PubMed ID: 12576963
    [Abstract] [Full Text] [Related]

  • 37. Matrix metalloproteinases and their tissue inhibitor after reperfused ST-elevation myocardial infarction treated with doxycycline. Insights from the TIPTOP trial.
    Cerisano G, Buonamici P, Gori AM, Valenti R, Sciagrà R, Giusti B, Sereni A, Raspanti S, Colonna P, Gensini GF, Abbate R, Schulz R, Antoniucci D.
    Int J Cardiol; 2015 Oct 15; 197():147-53. PubMed ID: 26134371
    [Abstract] [Full Text] [Related]

  • 38. Circulating level of gelatinase activity predicts ventricular remodeling in patients with acute myocardial infarction.
    Matsunaga T, Abe N, Kameda K, Hagii J, Fujita N, Onodera H, Kamata T, Ishizaka H, Hanada H, Osanai T, Okumura K.
    Int J Cardiol; 2005 Nov 02; 105(2):203-8. PubMed ID: 16243114
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Predictive utility of the changes in matrix metalloproteinase-2 in the early phase for left ventricular reverse remodeling after an acute myocardial infarction.
    Morishita T, Uzui H, Mitsuke Y, Arakawa K, Amaya N, Kaseno K, Ishida K, Nakaya R, Lee JD, Tada H.
    J Am Heart Assoc; 2015 Jan 23; 4(1):e001359. PubMed ID: 25616975
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.